Clinical Trials Logo

Hypospadias clinical trials

View clinical trials related to Hypospadias.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04826484 Terminated - Urologic Diseases Clinical Trials

Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel

Baby ORIOLES
Start date: October 1, 2021
Phase: Phase 3
Study type: Interventional

This study aims to evaluate the utility of long-acting liposomal bupivacaine (Exparel®) in improving pain scores and reducing narcotic pain requirements in pediatric patients following minor urologic procedures.

NCT ID: NCT02162810 Terminated - Hypospadias Clinical Trials

Effect of Steroids on Post-Operative Complications Following Proximal Hypospadias Repair

Start date: May 2014
Phase: N/A
Study type: Interventional

The primary objective of this study is to determine the efficacy of administering a course of postoperative oral steroids in pediatric patients undergoing proximal hypospadias repair as prevention against complications. Specifically, the study aims to assess if the steroids i) decrease the incidence of wound breakdown, fistula formation, stenosis or stricture formation, and the need for subsequent redo-hypospadias surgeries and/or fistula repairs and ii) improve the quality of wound healing including the overall cosmetic appearance of the phallus (i.e. location of the urethral meatus).

NCT ID: NCT01356420 Terminated - Clinical trials for Smith-Lemli-Opitz Syndrome

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

STAIR-SLOS
Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to learn about Smith-Lemli-Opitz Syndrome (SLOS). SLOS is an inherited condition that is caused by the body not making an enzyme as it should. The body needs the enzyme to help make cholesterol. SLOS can cause many health problems including slow growth and development, eating disorders, sleep disorders, behavior disorders, and eye diseases. Severe SLOS leads to birth defects and mental retardation and in many cases early death. The investigators plan to measure cholesterol and other sterol levels, perform clinical observations, whole body testing and imaging (brain MRIs), to learn more about the disease and its progression, differences in the clinical features among individuals with SLOS, and look at the effect of cholesterol supplementation in this condition. The study is an interventional study to characterize disease progression and correlations between clinical, biochemical and physiological features of the disease. The main hypothesis is that dietary cholesterol supplementation does not improve features of SLOS related to the brain (e.g. IQ, behavior).